{ "company_number": "07492681", "name": "Ascot Laboratories Limited", "url": "/company/07492681", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2011-01-14", "dissolved_on": null, "sic_codes": [ { "code": "21100", "description": "Manufacture of basic pharmaceutical products", "section": "C", "section_name": "Manufacturing", "url": "/sic/21100" } ], "registered_address": { "id": 2775476, "url": "/address/2775476", "line1": "ASCOT HOUSE 1 WARWICK PLACE", "line2": "WARWICK ROAD", "post_town": "BOREHAMWOOD", "county": "", "country": "ENGLAND", "postcode": "WD6 1UA" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07492681", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-02-28", "last_made_up": "2025-05-31", "category": "GROUP", "filings": [ { "url": "/company/07492681/accounts/2025-05-31", "pdf_url": "/company/07492681/accounts/2025-05-31.pdf", "made_up_date": "2025-05-31", "period_start": "2024-06-01", "period_end": "2025-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "66.00", "tangible_fixed_assets": "6782501.00", "debtors": "1168430.00", "cash_bank_in_hand": "975865.00", "current_assets": "3332609.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1430660.00", "total_assets_less_current_liabilities": "8213161.00", "net_assets_liabilities": "4982628.00", "called_up_share_capital": "762.00", "profit_loss_account_reserve": "3107556.00", "shareholder_funds": "762.00", "turnover": "8874239.00", "other_operating_income": null, "cost_sales": "5435253.00", "gross_profit_loss": "3438986.00", "administrative_expenses": "1869495.00", "raw_materials_consumables": null, "staff_costs": "3094122.00", "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "1569491.00", "profit_before_tax": "1266723.00", "tax_on_profit": "71954.00", "profit_loss_for_period": "1194769.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2026.zip" }, { "url": "/company/07492681/accounts/2024-05-31", "pdf_url": "/company/07492681/accounts/2024-05-31.pdf", "made_up_date": "2024-05-31", "period_start": "2024-05-31", "period_end": "2024-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "59.00", "tangible_fixed_assets": "1523098.00", "debtors": "4680595.00", "cash_bank_in_hand": "33101.00", "current_assets": "5898455.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4124642.00", "total_assets_less_current_liabilities": "5647740.00", "net_assets_liabilities": "4250788.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "762.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/07492681/accounts/2023-05-31", "pdf_url": "/company/07492681/accounts/2023-05-31.pdf", "made_up_date": "2023-05-31", "period_start": "2023-05-31", "period_end": "2023-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "55.00", "tangible_fixed_assets": "1643941.00", "debtors": "3765757.00", "cash_bank_in_hand": "395476.00", "current_assets": "4696986.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3354738.00", "total_assets_less_current_liabilities": "4998679.00", "net_assets_liabilities": "3461803.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "762.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2024.zip" }, { "url": "/company/07492681/accounts/2022-05-31", "pdf_url": "/company/07492681/accounts/2022-05-31.pdf", "made_up_date": "2022-05-31", "period_start": "2022-05-31", "period_end": "2022-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "42.00", "tangible_fixed_assets": "1128767.00", "debtors": "2559993.00", "cash_bank_in_hand": "146030.00", "current_assets": "3212651.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2431320.00", "total_assets_less_current_liabilities": "3560087.00", "net_assets_liabilities": "2666333.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "765.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2023.zip" }, { "url": "/company/07492681/accounts/2021-05-31", "pdf_url": "/company/07492681/accounts/2021-05-31.pdf", "made_up_date": "2021-05-31", "period_start": "2021-05-31", "period_end": "2021-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "35.00", "tangible_fixed_assets": "939391.00", "debtors": "928007.00", "cash_bank_in_hand": "1078255.00", "current_assets": "2409155.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1496738.00", "total_assets_less_current_liabilities": "2436129.00", "net_assets_liabilities": "1634116.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "765.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2022.zip" }, { "url": "/company/07492681/accounts/2020-05-31", "pdf_url": "/company/07492681/accounts/2020-05-31.pdf", "made_up_date": "2020-05-31", "period_start": "2020-05-31", "period_end": "2020-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "26.00", "tangible_fixed_assets": "1019865.00", "debtors": "713885.00", "cash_bank_in_hand": "282380.00", "current_assets": "1047357.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "152207.00", "total_assets_less_current_liabilities": "1172072.00", "net_assets_liabilities": "322675.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "765.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2021.zip" }, { "url": "/company/07492681/accounts/2019-05-31", "pdf_url": "/company/07492681/accounts/2019-05-31.pdf", "made_up_date": "2019-05-31", "period_start": "2019-05-31", "period_end": "2019-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "20.00", "tangible_fixed_assets": "1036313.00", "debtors": "363468.00", "cash_bank_in_hand": "32874.00", "current_assets": "436572.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-129751.00", "total_assets_less_current_liabilities": "906562.00", "net_assets_liabilities": "352173.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "765.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/07492681/accounts/2018-05-31", "pdf_url": "/company/07492681/accounts/2018-05-31.pdf", "made_up_date": "2018-05-31", "period_start": "2018-05-31", "period_end": "2018-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "12.00", "tangible_fixed_assets": "1092619.00", "debtors": "2089504.00", "cash_bank_in_hand": "313419.00", "current_assets": "2449534.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "53601.00", "total_assets_less_current_liabilities": "1146220.00", "net_assets_liabilities": "535189.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "765.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2019.zip" }, { "url": "/company/07492681/accounts/2017-05-31", "pdf_url": "/company/07492681/accounts/2017-05-31.pdf", "made_up_date": "2017-05-31", "period_start": "2017-05-31", "period_end": "2017-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": "12.00", "tangible_fixed_assets": "1251709.00", "debtors": "1314076.00", "cash_bank_in_hand": "589967.00", "current_assets": "1933010.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "412569.00", "total_assets_less_current_liabilities": "1664278.00", "net_assets_liabilities": "961679.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "760.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2018.zip" }, { "url": "/company/07492681/accounts/2016-05-31", "pdf_url": "/company/07492681/accounts/2016-05-31.pdf", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "937265.00", "debtors": "766352.00", "cash_bank_in_hand": "26617.00", "current_assets": "813880.00", "creditors_due_within_one_year": "937552.00", "creditors_due_after_one_year": "622201.00", "net_current_assets_liabilities": "-123672.00", "total_assets_less_current_liabilities": "813593.00", "net_assets_liabilities": "167652.00", "called_up_share_capital": "673.00", "profit_loss_account_reserve": "-557949.00", "shareholder_funds": "167652.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" }, { "url": "/company/07492681/accounts/2015-05-31", "pdf_url": "/company/07492681/accounts/2015-05-31.pdf", "made_up_date": "2015-05-31", "period_start": "2015-05-31", "period_end": "2015-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "806918.00", "debtors": "545814.00", "cash_bank_in_hand": "522861.00", "current_assets": "1068675.00", "creditors_due_within_one_year": "1286134.00", "creditors_due_after_one_year": "30350.00", "net_current_assets_liabilities": "-217459.00", "total_assets_less_current_liabilities": "589459.00", "net_assets_liabilities": "536377.00", "called_up_share_capital": "670.00", "profit_loss_account_reserve": "-159224.00", "shareholder_funds": "536377.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2016.zip" }, { "url": "/company/07492681/accounts/2013-05-31", "pdf_url": "/company/07492681/accounts/2013-05-31.pdf", "made_up_date": "2013-05-31", "period_start": "2013-05-31", "period_end": "2013-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "418533.00", "debtors": "37741.00", "cash_bank_in_hand": "3053.00", "current_assets": "40794.00", "creditors_due_within_one_year": "1030780.00", "creditors_due_after_one_year": "169970.00", "net_current_assets_liabilities": "-989986.00", "total_assets_less_current_liabilities": "-571453.00", "net_assets_liabilities": "-741423.00", "called_up_share_capital": "40.00", "profit_loss_account_reserve": "-741463.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2014.zip" }, { "url": "/company/07492681/accounts/2012-05-31", "pdf_url": "/company/07492681/accounts/2012-05-31.pdf", "made_up_date": "2012-05-31", "period_start": "2012-05-31", "period_end": "2012-05-31", "entity_name": "Ascot Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "71262.00", "debtors": "5721.00", "cash_bank_in_hand": "9335.00", "current_assets": "15056.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-397223.00", "total_assets_less_current_liabilities": "-325961.00", "net_assets_liabilities": "-325961.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-325963.00", "shareholder_funds": "-325961.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2012.zip" } ], "pdf_only_filings": [ { "made_up_date": "2014-05-31", "filing_date": "2015-03-11", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/07492681/accounts/2014-05-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07492681/filing-history/MzExODY3NDQ1OGFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07492681/filing-history" }, "confirmation_statement": { "next_due": "2027-05-17", "last_made_up": "2026-05-03" }, "officers": [], "psc": [ { "name": "Mr Bhavesh Amratlal Radia", "kind": "individual-person-with-significant-control", "person_url": "/person/664798", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Deepak Anantrai Ghelani", "kind": "individual-person-with-significant-control", "person_url": "/person/1273921", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-13T04:32:18.465226+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }